First quarter 2025 revenues of $3.0 billion; GAAP diluted EPS of $7.27 and non-GAAP diluted EPS(a) of $8.22First quarter 2025 Dupixent® global net sales (recorded by Sanofi) increased 19% to $3.67 bil ...

The US Supreme Court appeared likely to reject Labcorp’s bid to limit who can join a class action blind people brought ...

Aeva will be demonstrating Eve 1D at its booth #8418 at the Automate conference in Detroit from May 12-15. Samples are ...

Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today introduced the Aeva Eve™ 1 line of high-precision sensors, starting with Eve 1D, the industry's first FMCW-based ...

Although the definition of acute respiratory distress syndrome (ARDS) has undergone numerous revisions aimed at enhancing its diagnostic accuracy and clinical practicality, the usefulness and ...

The Company announced a 10-year agreement with FUJIFILM Diosynth Biotechnologies (Fujifilm) to manufacture and supply Regeneron's commercial bulk drug product at Fujifilm's North Carolina campus. The ...

Following results from their new retrospective study, the researchers suggested that immediate reconstruction of the nose ...

Below, we are tracking the entire 2022 class -- all but one is eligible for a fifth-year option -- and updating as teams make their decisions. According to OverTheCap.com, the 2020 collective ...

Aeva, a Californian developer of next-generation sensing and perception systems, has announced the first laser displacement ...

1 Castle Point Terrace, Hoboken, NJ 07030, 201.216.5000 ...